| Active Not Recruiting | A Community-Based Screening Program to Identify Participants at High Risk for Amyloid Pathology Alzheimer's Disease | — | 2023-09-12 |
| Completed | A Study to Determine the Absolute Bioavailability and the Absorption, Metabolism, and Elimination Properties o Healthy Volunteers | Phase 1 | 2022-10-17 |
| Withdrawn | A Study to Evaluate the Relative Bioavailability of E7386 Following Oral Administration of Targeted Release (T Healthy Volunteers | Phase 1 | 2021-04-09 |
| Completed | A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Healthy Volunteers | Phase 1 | 2020-09-09 |
| Completed | A Study to Investigate Dosage, Effectiveness, and Safety of Perampanel When Used as First Add-on Therapy in Pa Idiopathic Generalized Epilepsy, Partial Onset Seizures, Generalised Tonic-Clonic Seizures | — | 2020-07-20 |
| Completed | A Study of Perampanel as Add-on Therapy in Adult and Adolescent Participants With Focal Seizures Partial Seizures | — | 2016-01-03 |
| Completed | Study of Lenvatinib in Children and Adolescents With Refractory or Relapsed Solid Malignancies and Young Adult Tumors, Solid Malignant Tumors, Osteosarcoma | Phase 1 / Phase 2 | 2014-12-29 |
| Completed | Extended Treatment in Metastatic Breast Cancer With Eribulin Breast Cancer | — | 2013-11-01 |
| Completed | Eribulin Use for the Treatment of Advanced Breast Cancer: A Prospective Observational Registry Breast Cancer | — | 2013-08-01 |
| Completed | A Multicenter, Open-Label, Phase 3 Trial to Compare the Efficacy and Safety of Lenvatinib (E7080) Versus Soraf Hepatocellular Carcinoma (HCC) | Phase 3 | 2013-03-01 |
| Completed | An Open-label, Multicenter, Multiple Dose, Phase 1 Study to Establish the Maximum Tolerated Dose of E7389 Lipo Solid Tumors | Phase 1 | 2012-12-11 |
| Completed | An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Ag Malignant Solid Tumour, Ovarian Cancer, Triple Negative Breast Cancer | Phase 1 / Phase 2 | 2012-01-01 |
| Completed | A 24-weeks, Multi-center, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safe Alzheimer's Type Dementia | Phase 3 | 2011-09-01 |
| Completed | Pharmacokinetics and Food Effect of Single Oral Dose of E7050 in Healthy Volunteers Healthy Subjects | Phase 1 | 2010-11-01 |
| Completed | A Placebo-Controlled, Double-Blind Comparative Study of E2080 in Lennox-Gastaut Syndrome Patients (Study E2080 Lennox-Gastaut Syndrome | Phase 3 | 2010-06-01 |
| Completed | A Study in Healthy Subjects to Determine the Effects When Alcohol is Administered With Perampanel Central Nervous System | Phase 1 | 2010-05-01 |
| Completed | A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Saf Psoriasis Vulgaris | Phase 2 | 2010-03-15 |
| Completed | A Confirmation Study of Eribulin in Combination With Capecitabine Metastatic Breast Cancer | Phase 1 / Phase 2 | 2010-01-26 |
| Completed | To Assess the Effect of Rifampicin on the Pharmacokinetics of Eribulin Mesylate in Participants With Advanced Tumor | Phase 1 | 2009-12-01 |
| Completed | QT Interval Prolongation Study of Eribulin Mesylate (E7389) in Patients With Advanced Solid Tumors Advanced Solid Tumor | Phase 1 | 2009-03-01 |
| Completed | Evaluating the Pharmacokinetics and Tolerance of Co-administration of Oral Multiple Dose of Ketoconazole and a Cancer | Phase 1 | 2009-02-01 |
| Terminated | A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in El Epilepsy | Phase 4 | 2008-11-01 |
| Terminated | Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures Epilepsy | Phase 3 | 2008-08-01 |
| Completed | A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Partial Seizures | Phase 3 | 2008-07-01 |
| Completed | Comparing The Effect On Cognition Of Adjunctive Therapy With Zonisamide Versus Sodium Valproate Epilepsy | Phase 4 | 2008-06-01 |
| Completed | European Registry of Anti-Epileptic Drug Use in Patients With Lennox-Gastaut Syndrome (LGS) Lennox-Gastaut Syndrome | — | 2008-06-01 |
| Terminated | Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epil Epilepsy | Phase 3 | 2008-06-01 |
| Completed | Patient Registry of Intrathecal Pain Management in Europe for Prialt (Ziconotide Intrathecal Infusion) and Alt Pain Management, Severe Chronic Pain | — | 2008-04-01 |
| Terminated | Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy Parkinson's Disease | Phase 3 | 2007-07-01 |
| Suspended | A Dose Escalation Study of E7107 Administered IV (Bolus) on Days 1, 8, and 15 Every 28 Days to Patients With S Cancer | Phase 1 | 2007-05-01 |
| Terminated | Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctua Parkinson's Disease | Phase 3 | 2006-11-01 |
| Completed | The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Flu Parkinson's Disease | Phase 3 | 2006-02-01 |
| Completed | An Electrophysiological Study Of E2014 In Healthy Adult Male Japanese And Caucasian Subjects Spasmodic Torticollis | Phase 2 | 2006-01-01 |
| Completed | Open Label, Zonegran (Zonisamide) In Partial Onset Seizures Epilepsy | Phase 4 | 2005-10-01 |
| Completed | An Open Label Phase II Study of Indisulam in Combination With Irinotecan in Patients With Metastatic Colorecta Colorectal Cancer | Phase 2 | 2005-04-01 |
| Completed | The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Im Cognitive Impairment | Phase 2 | 2005-02-01 |
| Terminated | An Open-label, Randomized, Phase II Study of the Efficacy and Safety of Indisulam (E7070) in Combination With Metastatic Breast Cancer | Phase 2 | 2004-12-01 |
| Completed | A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Pat Lesion | Phase 2 | 2004-11-01 |
| Completed | A Comparative Study of KES524 in Patients With Obesity Disease Obesity | Phase 3 | 2004-07-01 |
| Completed | A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of Parkinson's Disease | Phase 2 | 2004-05-01 |
| Terminated | A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular Carcinoma Hepatocellular Carcinoma | Phase 2 / Phase 3 | 2004-03-01 |
| Completed | Study of E7070 Combined With Capecitabine to Determine Efficacy and Recommended Dose of Combination in Patient Colorectal Cancer (CRC) | Phase 2 | 2003-03-01 |
| Completed | A Multi-Center, Randomized, Double-Blind, Parallel Group Study With 3 Groups Receiving Placebo, 5 mg of E2020 Alzheimer Disease | Phase 2 | 2002-11-01 |
| Completed | The Efficacy, Tolerability and Safety of Donepezil (Aricept) in Parkinson's Disease Patients With Dementia Dementia With Parkinson's Disease | Phase 3 | 2002-08-01 |
| Completed | The Effect of Vitamin K2 on Bone Turnover Osteoporosis | Phase 4 | 2002-02-01 |
| Completed | Randomized, Open, Parallel, Active Controlled Study on Fracture Prevention in Antiosteoporosis Treatment (OF S Osteoporosis | Phase 4 | 1996-04-01 |